(LEAD) SK Biopharmaceuticals turns to black in Q4 on higher U.S. sales
SEOUL, SK Biopharmaceuticals Co. said Monday it shifted to net profit in the fourth quarter from a net loss a year earlier, driven by higher sales in the United States.
The net profit came to 7.8 billion won (US$5.8 million) in the October-December …